Canada Relies On Emergent Data To Vouch For AstraZeneca Vaccine Donated By U.S.

Canada’s drug regulation authority is relying on information provided by Emergent BioSolutions’ troubled manufacturing facility in Baltimore, which recently halted its production of COVID-19 vaccines after an FDA inspection found deficient manufacturing practices dating back to February, to vouch for millions of doses of AstraZeneca’s COVID-19 vaccine donated by the United States last month prior to the inspection findings. FDA conducted an inspection at the partially government-funded facility after Johnson & Johnson took over manufacturing in early April 2021 due...